Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2023-05-31 Purchase |
2023-06-02 5:03 pm |
Terns Pharmaceuticals Inc. | TERN | Sundaram Senthil Vel Chief Executive Officer |
2,111 | $1.41 | $2,977 | 9,770 (Direct) |
View |
| 2022-11-30 Purchase |
2023-02-03 6:00 pm |
Terns Pharmaceuticals Inc. | TERN | Sundaram Senthil Vel Chief Executive Officer |
3 | $1.41 | $4 | 907,659 (Direct) |
View |
| 2022-05-31 Purchase |
2022-06-08 9:27 pm |
Terns Pharmaceuticals Inc. | TERN | Sundaram Senthil Vel Chief Executive Officer |
7,656 | $1.47 | $11,254 | 7,656 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2023-02-01 Option Award |
2023-02-03 6:00 pm |
N/A 2033-01-31 |
Terns Pharmaceuticals Inc. | TERN | Sundaram Senthil Vel Chief Executive Officer |
900,000 | $0 | 907,659 (Direct) |
View |
| 2022-01-26 Option Award |
2022-01-28 9:00 pm |
N/A 2032-01-26 |
Terns Pharmaceuticals Inc. | TERN | Sundaram Senthil Vel Chief Executive Officer |
280,000 | $0 | 280,000 (Direct) |
View |
| 2021-09-28 Option Award |
2021-09-30 9:13 pm |
N/A 2031-09-28 |
Terns Pharmaceuticals Inc. | TERN | Sundaram Senthil Vel Chief Executive Officer |
315,000 | $0 | 315,000 (Direct) |
View |
| 2021-04-15 Option Award |
2021-04-19 4:56 pm |
N/A 2031-04-14 |
Sio Gene Therapies Inc. | SIOX | Sundaram Senthil Vel Director |
42,000 | $0 | 42,000 (Direct) |
View |
Ownership |
2021-02-04 5:16 pm |
N/A 2030-08-12 |
Terns Pharmaceuticals Inc. | TERN | Sundaram Senthil Vel Chief Executive Officer |
0 | $0 | 949,197 (Direct) |
View |